Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.

Prabakaran M, Meng T, He F, Yunrui T, Qiang J, Lin RT, Kwang J.

Clin Vaccine Immunol. 2011 Sep;18(9):1582-5. doi: 10.1128/CVI.05114-11. Epub 2011 Jul 13.

PMID:
21752948
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

Prabakaran M, Madhan S, Prabhu N, Qiang J, Kwang J.

J Virol. 2010 Apr;84(7):3201-9. doi: 10.1128/JVI.02175-09. Epub 2010 Jan 13.

PMID:
20071572
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.

PMID:
18786689
[PubMed - indexed for MEDLINE]
Free Article
4.

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.

Vaccine. 2007 May 10;25(19):3871-8. Epub 2007 Feb 15.

PMID:
17337102
[PubMed - indexed for MEDLINE]
5.

Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.

Prabakaran M, Kolpe AB, He F, Kwang J.

Vaccine. 2013 Feb 27;31(10):1385-92. doi: 10.1016/j.vaccine.2013.01.003. Epub 2013 Jan 14.

PMID:
23328313
[PubMed - indexed for MEDLINE]
6.

Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.

Kim YC, Yoo DG, Compans RW, Kang SM, Prausnitz MR.

J Control Release. 2013 Dec 10;172(2):579-88. doi: 10.1016/j.jconrel.2013.04.016. Epub 2013 Apr 30.

PMID:
23643528
[PubMed - indexed for MEDLINE]
7.

Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.

Rajesh Kumar S, Syed Khader SM, Kiener TK, Szyporta M, Kwang J.

PLoS One. 2013 Jun 7;8(6):e63856. doi: 10.1371/journal.pone.0063856. Print 2013.

PMID:
23762234
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Vaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity.

Bayne AC, Boltz D, Owen C, Betz Y, Maia G, Azadi P, Archer-Hartmann S, Zirkle R, Lippmeier JC.

PLoS One. 2013 Apr 23;8(4):e61790. doi: 10.1371/journal.pone.0061790. Print 2013.

PMID:
23626728
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice.

Prabakaran M, Madhan S, Prabhu N, Geng GY, New R, Kwang J.

Antiviral Res. 2010 May;86(2):180-7. doi: 10.1016/j.antiviral.2010.02.315. Epub 2010 Feb 12.

PMID:
20153776
[PubMed - indexed for MEDLINE]
10.

Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.

Ichinohe T, Ainai A, Nakamura T, Akiyama Y, Maeyama J, Odagiri T, Tashiro M, Takahashi H, Sawa H, Tamura S, Chiba J, Kurata T, Sata T, Hasegawa H.

J Med Virol. 2010 Jan;82(1):128-37. doi: 10.1002/jmv.21670.

PMID:
19950232
[PubMed - indexed for MEDLINE]
11.

Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus.

Shim BS, Choi JA, Song HH, Park SM, Cheon IS, Jang JE, Woo SJ, Cho CH, Song MS, Kim H, Song KJ, Lee JM, Kim SW, Song DS, Choi YK, Kim JO, Nguyen HH, Kim DW, Bahk YY, Yun CH, Song MK.

J Microbiol. 2013 Feb;51(1):130-5. doi: 10.1007/s12275-013-2399-z. Epub 2013 Mar 2.

PMID:
23456722
[PubMed - indexed for MEDLINE]
12.

[Chitosan as an adjuvant for parenteral inactivated influenza vaccines].

Gendon IuZ, Markushin SG, Krivtsov GG, Akopova II.

Vopr Virusol. 2008 Sep-Oct;53(5):14-9. Russian.

PMID:
19069787
[PubMed - indexed for MEDLINE]
13.

Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.

Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.

PMID:
22537989
[PubMed - indexed for MEDLINE]
14.

Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection.

Easterbrook JD, Kash JC, Sheng ZM, Qi L, Gao J, Kilbourne ED, Eichelberger MC, Taubenberger JK.

Influenza Other Respir Viruses. 2011 May;5(3):198-205. doi: 10.1111/j.1750-2659.2010.00191.x. Epub 2011 Jan 25.

PMID:
21477139
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus.

Harris K, Ream R, Gao J, Eichelberger MC.

Virol J. 2011 May 21;8:251. doi: 10.1186/1743-422X-8-251.

PMID:
21600020
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Endocine™, N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination.

Falkeborn T, Bråve A, Larsson M, Akerlind B, Schröder U, Hinkula J.

PLoS One. 2013 Aug 8;8(8):e70527. doi: 10.1371/journal.pone.0070527. eCollection 2013.

PMID:
23950951
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.

Choi JY, Gwon YD, Kim JK, Cho YD, Heo YK, Cho HS, Choi TJ, Poo HR, Oh YK, Kim YB.

PLoS One. 2013 Nov 18;8(11):e80762. doi: 10.1371/journal.pone.0080762. eCollection 2013.

PMID:
24260476
[PubMed - indexed for MEDLINE]
Free PMC Article
19.
20.

Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.

Chen J, Zhang F, Fang F, Chang H, Chen Z.

BMC Infect Dis. 2007 Oct 16;7:118.

PMID:
17939857
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk